The roles of FRCs in HIV-1 spread and establishment of latency

FRC 在 HIV-1 传播和潜伏期建立中的作用

基本信息

  • 批准号:
    10759591
  • 负责人:
  • 金额:
    $ 19.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Secondary lymphoid organs including lymph nodes (LNs) are a major site for HIV-1 spread. Furthermore, secondary lymphoid organs harbor viral reservoirs, which are a barrier to curing AIDS. Follicular helper T cells and follicular dendritic cells in B cell follicles are well studied as viral reservoirs in LNs. Notably, in addition to B cell follicles, T cell zones (TCZs) within LNs contain bona fide latent and persistent viral reservoirs in antiretroviral therapy-suppressed HIV-1 patients. However, despite the potential of TCZs as a source of viral reservoirs, how HIV-1 disseminates and how viral reservoirs are generated in TCZs are poorly understood. In this application, we propose to determine the effect of TCZ fibroblastic reticular cells (TRCs) on HIV-1 and SIV spread and latency establishment. We previously demonstrated that TRCs isolated from human LNs mediate trans-infection of HIV- 1 and that the interaction between hyaluronan (a polysaccharide) and CD44 plays a key role in this process. Additionally, our preliminary experiments showed that TRCs render resting CD4+ T cells, the most abundant cell group in TCZs, permissive to both productive and latent infection when the T cells are cocultured with TRCs prior to infection. Therefore, it is possible that the interactions between resting CD4+ T cells and TRCs promote HIV- 1 spread by two mechanisms, i.e., enhancing of permissiveness to HIV-1 infection and mediating trans-infection. However, it is unknown whether TRCs mediate trans-infection of HIV-1 through CD44-hyaluronan interactions in vivo and how TRCs enhance the permissiveness of resting CD4+ T cells to productive and latent infection. We will investigate whether TRCs isolated from rhesus macaque LNs mediate trans-infection of SIV via CD44- hyaluronan interactions ex vivo. This investigation allows us to determine the extent of conservation of the trans- infection mechanism described above and the usefulness of an in vivo SIV/rhesus macaque model for studies of TRC-dependent HIV-1 spread in secondary lymphoid organs. Additionally, we will identify the TRC factors that render resting CD4+ T cells permissive to HIV-1 infection and define the roles of TRCs in latency establishment in TCZs. Completion of the proposed research establishes the basis for a mechanistic understanding of the roles of TRCs in HIV dissemination and latency and could contribute to the development of a strategy inhibiting latency establishment.
包括淋巴结(LN)在内的次级淋巴器官是HIV-1传播的主要部位。此外,委员会认为, 次级淋巴器官藏有病毒储存库,这是治愈艾滋病的障碍。滤泡辅助T细胞 B细胞滤泡中的滤泡树突状细胞作为LN中的病毒储库被充分研究。值得注意的是,除了B 淋巴结内的T细胞区(TCZ)在抗逆转录病毒治疗中含有真正的潜伏性和持久性病毒库。 治疗抑制的HIV-1患者。然而,尽管TCZ作为病毒库的来源具有潜力, HIV-1的传播以及TCZ中病毒储库是如何产生的还知之甚少。在本申请中, 我们建议确定TCZ成纤维网状细胞(TRC)对HIV-1和SIV传播和潜伏期的影响 建立。我们以前证明,从人淋巴结中分离的TRCs介导HIV-1的转感染。 1,透明质酸(一种多糖)和CD 44之间的相互作用在这一过程中起着关键作用。 此外,我们的初步实验表明,TRCs使静息的CD 4 + T细胞,最丰富的细胞, TCZ组,当T细胞与TRC共培养时,允许生产性和潜伏性感染, 感染因此,静息CD 4 + T细胞和TRCs之间的相互作用可能促进HIV-1。 1通过两种机制传播,即,增强对HIV-1感染的容许性,介导交叉感染。 然而,TRC是否通过CD 44-透明质酸相互作用介导HIV-1的转感染尚不清楚 以及TRC如何增强静息CD 4 + T细胞对生产性和潜伏性感染的容许性。我们 将研究从恒河猴淋巴结中分离的TRCs是否通过CD 44- 离体透明质酸相互作用。这项调查使我们能够确定跨- 上述感染机制和体内SIV/恒河猴模型用于研究的有用性 TRC依赖的HIV-1在次级淋巴器官中传播。此外,我们将确定TRC因素 这使得静息的CD 4 + T细胞允许HIV-1感染,并定义了TRC在潜伏期中的作用。 在TCZ中建立。完成拟议的研究奠定了基础, 了解TRCs在艾滋病毒传播和潜伏期中的作用,并有助于制定 抑制潜伏期建立的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tomoyuki Murakami其他文献

Tomoyuki Murakami的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了